Literature DB >> 3121374

A direct effect of glucocorticoid hormones on the ability of human and murine macrophages to control the growth of M. tuberculosis.

G A Rook1, J Steele, M Ainsworth, C Leveton.   

Abstract

Recombinant murine Gamma interferon (rIFN-gamma) causes powerful inhibition of M. tuberculosis by murine peritoneal macrophages. This inhibition is totally abrogated by glucocorticosteroid hormones. In contrast, glucocorticoids do not oppose the weak inhibition of M. tuberculosis by human macrophages which can be induced with human rIFN-gamma, nor do they reduce the effect in this system of 1,25-(OH)2 vitamin D3. However, glucocorticoid hormones do decrease the baseline inhibition of M. tuberculosis exerted by monocytes from some normal human donors without any preincubation in an activating stimulus. Thus there is a steroid-sensitive anti-mycobacterial mechanism in human macrophages, but IFN-gamma is not the lymphokine which induces it. We suggest that this mechanism may be important for protection and steroid-induced reactivation, and deserves further study. On the other hand, the IFN-gamma and vitamin D3 pathway may be more relevant to immunopathology.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3121374

Source DB:  PubMed          Journal:  Eur J Respir Dis        ISSN: 0106-4339


  10 in total

1.  Mechanisms of recrudescence of Mycobacterium bovis BCG infection in mice.

Authors:  J H Cox; B C Knight; J Ivanyi
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

2.  Dichotomous role of the macrophage in early Mycobacterium marinum infection of the zebrafish.

Authors:  Hilary Clay; J Muse Davis; Dana Beery; Anna Huttenlocher; Susan E Lyons; Lalita Ramakrishnan
Journal:  Cell Host Microbe       Date:  2007-07-12       Impact factor: 21.023

Review 3.  Tuberculosis.

Authors:  A Zumla; J Grange
Journal:  BMJ       Date:  1998-06-27

4.  Effects of in vitro HIV-1 infection on mycobacterial growth in peripheral blood monocyte-derived macrophages.

Authors:  Sharad Pathak; Tore Wentzel-Larsen; Birgitta Asjö
Journal:  Infect Immun       Date:  2010-07-12       Impact factor: 3.441

5.  Identification of nitric oxide synthase as a protective locus against tuberculosis.

Authors:  J D MacMicking; R J North; R LaCourse; J S Mudgett; S K Shah; C F Nathan
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

6.  Extensive Mycobacterium bovis BCG infection of liver parenchymal cells in immunocompromised mice.

Authors:  J W Mills; L Ryan; R LaCourse; R J North
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

7.  Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism.

Authors:  Kristin N Adams; Kevin Takaki; Lynn E Connolly; Heather Wiedenhoft; Kathryn Winglee; Olivier Humbert; Paul H Edelstein; Christine L Cosma; Lalita Ramakrishnan
Journal:  Cell       Date:  2011-03-03       Impact factor: 41.582

8.  Interactions between hormone-mediated and vaccine-mediated immunotherapy for pulmonary tuberculosis in BALB/c mice.

Authors:  R Hernandez-Pando; L Pavon; E H Orozco; J Rangel; G A Rook
Journal:  Immunology       Date:  2000-07       Impact factor: 7.397

9.  The effects of androstenediol and dehydroepiandrosterone on the course and cytokine profile of tuberculosis in BALB/c mice.

Authors:  R Hernandez-Pando; M De La Luz Streber; H Orozco; K Arriaga; L Pavon; S A Al-Nakhli; G A Rook
Journal:  Immunology       Date:  1998-10       Impact factor: 7.397

10.  Regulation of mycobacterial growth by the hypothalamus-pituitary-adrenal axis: differential responses of Mycobacterium bovis BCG-resistant and -susceptible mice.

Authors:  D H Brown; J Sheridan; D Pearl; B S Zwilling
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.